Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:00 pm Purchase |
2024-12-31 | 13G | Altice USA, Inc. ATUS |
Empyrean Capital Partners, LP | 17,500,000 6.300% |
17,500,000 (New Position) |
Filing History |
| 2025-02-14 4:00 pm Purchase |
2024-12-31 | 13G | Churchill Capital Corp IX Ordinary Shares CCIX |
Empyrean Capital Partners, LP | 2,900,000 9.800% |
1,150,000 (+65.71%) |
Filing History |
| 2024-11-14 4:11 pm Purchase |
2024-09-30 | 13G | Acadian Asset Management AAMI |
Empyrean Capital Partners, LP | 1,880,634 5.070% |
1,880,634 (New Position) |
Filing History |
| 2024-11-14 4:11 pm Purchase |
2024-09-30 | 13G | Churchill Capital Corp IX Ordinary Shares CCIX |
Empyrean Capital Partners, LP | 1,750,000 5.940% |
1,750,000 (New Position) |
Filing History |
| 2024-11-14 4:11 pm Sale |
2024-09-30 | 13G | Oklo Inc. OKLO |
Empyrean Capital Partners, LP | 0 0.000% |
-3,056,992 (Position Closed) |
Filing History |
| 2024-02-14 09:00 am Unchanged |
2023-12-31 | 13G | AEON Biopharma, Inc. AEON |
Empyrean Capital Partners, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 09:00 am Sale |
2023-12-31 | 13G | Oklo Inc. OKLO |
Empyrean Capital Partners, LP | 3,056,992 9.990% |
-1,790,134 (-36.93%) |
Filing History |
| 2024-02-14 09:00 am Sale |
2023-12-31 | 13G | Bristow Group Inc. VTOL |
Empyrean Capital Partners, LP | 1,027,914 3.640% |
-607,552 (-37.15%) |
Filing History |
| 2024-02-14 09:00 am Sale |
2023-12-31 | 13G | Catcha Investment Corp CHAA |
Empyrean Capital Partners, LP | 0 0.000% |
-1,850,000 (Position Closed) |
Filing History |
| 2024-02-14 09:00 am Sale |
2023-12-31 | 13G | Churchill Capital Corp VI CCVI |
Empyrean Capital Partners, LP | 0 0.000% |
-4,424,157 (Position Closed) |
Filing History |
| 2024-02-14 09:00 am Unchanged |
2023-12-31 | 13G | Mobile Infrastructure Corporation BEEP |
Empyrean Capital Partners, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 09:00 am Unchanged |
2023-12-31 | 13G | Warburg Pincus Capital Corporation I-A WPCA |
Empyrean Capital Partners, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 06:38 am Unchanged |
2022-12-31 | 13G | ScION Tech Growth I SCOA |
Empyrean Capital Partners, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 06:37 am Purchase |
2021-12-31 | 13G | Prospector Capital Corp. PRSR |
Empyrean Capital Partners, LP | 1,073,832 3.300% |
1,073,832 (New Position) |
Filing History |
| 2023-02-14 06:36 am Unchanged |
2021-12-31 | 13G | Pontem Corporation PNTM |
Empyrean Capital Partners, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 06:34 am Unchanged |
2022-12-31 | 13G | Periphas Capital Partnering Corporation PCPC |
Empyrean Capital Partners, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 06:33 am Unchanged |
2021-12-31 | 13G | eFFECTOR Therapeutics, Inc. EFTR |
Empyrean Capital Partners, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 06:31 am Unchanged |
2021-12-31 | 13G | Xos, Inc. XOS |
Empyrean Capital Partners, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 06:30 am Unchanged |
2021-12-31 | 13G | Rover Group, Inc. ROVR |
Empyrean Capital Partners, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 06:29 am Unchanged |
2021-12-31 | 13G | Legacy EJY, Inc. ENJYQ |
Empyrean Capital Partners, LP | 0 0.000% |
0 (Unchanged) |
Filing History |